No Increased Risk of Inflammatory Bowel Disease Among Secukinumab-Treated Patients with Moderate to Severe Psoriasis, Psoriatic Arthritis, or Ankylosing Spondylitis: Data from 14 Phase 2 and Phase 3 Clinical Studies

被引：0
|
作者：
Deodhar, Atul A. [1 ]
Schreiber, Stefan [2 ]
Gandhi, Kunal [3 ]
Fox, Todd [4 ]
Gaillez, Corine [4 ]
Karyekar, Chetan [3 ]
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[2] Christian Albrechts Univ Kiel, Kiel, Germany
[3] Novartis Pharmaceut, E Hanover, NJ USA
[4] Novartis Pharma AG, Basel, Switzerland
来源：
ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
962
引用
收藏
页数：3
相关论文
共 50 条
  • [1] NO INCREASED RISK OF INFLAMMATORY BOWEL DISEASE AMONG SECUKINUMAB-TREATED PATIENTS WITH MODERATE TO SEVERE PSORIASIS, PSORIATIC ARTHRITIS, OR ANKYLOSING SPONDYLITIS: DATA FROM 14 PHASE 2 AND PHASE 3 CLINICAL STUDIES
    Zochling, J.
    Deodhar, A.
    Schreiber, S.
    Gandhi, K.
    Fox, T.
    Gaillez, C.
    Karyekar, C.
    INTERNAL MEDICINE JOURNAL, 2017, 47 : 38 - 39
  • [2] NO INCREASED INCIDENCE OF INFLAMMATORY BOWEL DISEASE AMONG SECUKINUMAB-TREATED PATIENTS WITH MODERATE TO SEVERE PSORIASIS, PSORIATIC ARTHRITIS, OR ANKYLOSING SPONDYLITIS: DATA FROM 14 PHASE 2 AND PHASE 3 CLINICAL STUDIES
    Schreiber, S.
    Sands, B. E.
    Deodhar, A.
    Baeten, D.
    Huang, J.
    Gandhi, K.
    Karyekar, C.
    Fox, T.
    Gaillez, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 97 - 98
  • [3] The risk of malignancy in patients with secukinumab-treated psoriasis, psoriatic arthritis and ankylosing spondylitis
    van de Kerkhof, P. C. M.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (05) : 879 - 879
  • [4] INCIDENCE OF INFLAMMATORY BOWEL DISEASE IN PATIENTS TREATED WITH SECUKINUMAB: POOLED ANALYSIS OF 21 RANDOMISED CONTROLLED PHASE 3/ 4 CLINICAL TRIALS OF PSORIASIS, PSORIATIC ARTHRITIS, AND ANKYLOSING SPONDYLITIS
    Schreiber, Stefan
    Colombel, Jean-Frederic
    Feagan, Brian G.
    Reich, Kristian
    Deodhar, Atul
    McInnes, Iain B.
    Porter, Brian
    Das Gupta, Ayan
    Pricop, Luminita
    Fox, Todd
    ACTA DERMATO-VENEREOLOGICA, 2018, 98 : 18 - 18
  • [5] Incidence of Uveitis in Secukinumab-treated Patients With Ankylosing Spondylitis: Pooled Data Analysis From Three Phase 3 Studies
    Deodhar, Atul A.
    Miceli-Richard, Corine
    Baraliakos, Xenofon
    Marzo-Ortega, Helena
    Gladman, Dafna D.
    Blanco, Ricardo
    Das Gupta, Ayan
    Martin, Ruvie
    Safi, Jorge
    Porter, Brian
    Shete, Abhijit
    Rosenbaum, James T.
    ACR OPEN RHEUMATOLOGY, 2020, 2 (05) : 294 - 299
  • [6] Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials
    Schreiber, Stefan
    Colombel, Jean-Frederic
    Feagan, Brian G.
    Reich, Kristian
    Deodhar, Atul A.
    McInnes, Iain B.
    Porter, Brian
    Das Gupta, Ayan
    Pricop, Luminita
    Fox, Todd
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (04) : 473 - 479
  • [7] The risk of malignancy in patients with secukinumab-treated psoriasis, psoriatic arthritis and ankylosing spondylitis: analysis of clinical trial and postmarketing surveillance data with up to five years of follow-up
    Lebwohl, M.
    Deodhar, A.
    Griffiths, C. E. M.
    Menter, M. A.
    Poddubnyy, D.
    Bao, W.
    Jehl, V.
    Marfo, K.
    Primatesta, P.
    Shete, A.
    Trivedi, V.
    Mease, P. J.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (05) : 935 - 944
  • [8] Real-Life Data of Secukinumab in Patients with Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis: Patient Baseline Characteristics Data from the PROMPT Study
    Rattanakaemakorn, Ploysyne
    Chevaisrakul, Parawee
    Wongpraparut, Chanisada
    Chiowchanwisawakit, Praveena
    Tovanabutra, Napatra
    Tantiwong, Pimchanok
    Amornpinyo, Warayuwadee
    Chakkavittumrong, Panlop
    Hanvivadhanakul, Punchong
    Chaiamnuay, Sumapa
    Laodheerasiri, Supapat
    Pattamadilok, Bensachee
    Choonhakarn, Charoen
    Mahakkanukrauh, Ajanee
    Aiewruengsurat, Duangkamol
    Sangmala, Siripan
    Pretikul, Nisa
    Sumethkul, Kittiwan
    Satpanich, Panchalee
    Boonsiri, Metavee
    Sangob, Naruemon
    Asawanonda, Pravit
    DERMATOLOGY AND THERAPY, 2024, 14 (12) : 3229 - 3241
  • [9] Secukinumab Use in Patients with Moderate to Severe Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis in Real-World Setting in Europe: Baseline Data from SERENA Study
    Kiltz, Uta
    Sfikakis, Petros P.
    Gaffney, Karl
    Sator, Paul-Gunther
    von Kiedrowski, Ralph
    Bounas, Andreas
    Gullick, Nicola
    Conrad, Curdin
    Rigopoulos, Dimitris
    Lespessailles, Eric
    Romanelli, Marco
    Ghislain, Pierre-Dominique
    Brandt-Juergens, Jan
    Rashkov, Rasho
    Aassi, Maher
    Orsenigo, Roberto
    Perella, Chiara
    Pournara, Effie
    Gathmann, Sven
    Jagiello, Piotr
    Veit, Justyna
    Augustin, Matthias
    ADVANCES IN THERAPY, 2020, 37 (06) : 2865 - 2883
  • [10] Secukinumab Use in Patients with Moderate to Severe Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis in Real-World Setting in Europe: Baseline Data from SERENA Study
    Uta Kiltz
    Petros P. Sfikakis
    Karl Gaffney
    Paul-Gunther Sator
    Ralph von Kiedrowski
    Andreas Bounas
    Nicola Gullick
    Curdin Conrad
    Dimitris Rigopoulos
    Eric Lespessailles
    Marco Romanelli
    Pierre-Dominique Ghislain
    Jan Brandt-Jürgens
    Rasho Rashkov
    Maher Aassi
    Roberto Orsenigo
    Chiara Perella
    Effie Pournara
    Sven Gathmann
    Piotr Jagiello
    Justyna Veit
    Matthias Augustin
    Advances in Therapy, 2020, 37 : 2865 - 2883
12345